Back to Search
Start Over
ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3–targeting antibody-drug conjugate, in patients with advanced solid tumor.
- Source :
- Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3017-3017, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 41
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 164013664
- Full Text :
- https://doi.org/10.1200/JCO.2023.41.16_suppl.3017